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Background: There is widespread use of Complementary and Alternative Medicine (CAM) in Ghana, driven by
cultural consideration and paradigm to disease causation. Whether there is concurrent use of conventional
medicine and CAM in cancer patients is unknown. This study investigates the prevalence, pattern and predictors of
CAM use in cancer patients. Overlapping toxicity, sources of information, and whether users inform their doctor
about CAM use is examined.
Method: Cross-sectional study using a questionnaire administered to cancer patients, who were receiving
radiotherapy and or chemotherapy or had recently completed treatment at a single institution was used.
Results: Ninety eight patients participated in the study with a mean age of 55.5 (18–89), made up of 51% females.
Married individuals formed 56% of the respondents, whilst 49% had either secondary or tertiary education. Head
and neck cancer patients were 15.3%, breast (21.4%), abdomen/pelvic cancers constituted (52%).Seventy seven
(78.6%) patients received radiotherapy only, 16.3% received radiation and chemotherapy and 5.3% had
chemotherapy only.
Ninety five patients were diagnosed of cancer within the past 24 months,73.5% were CAM users as follows;
massage(66.3%), herbal(59.2%), mega vitamins(55.1%), Chinese medicine(53.1%),and prayer(42.9%). Sixty eight
percent were treated with curative intent. Overlapping toxicity was reported. Majority (83.3%) of users had not
informed their doctor about CAM use.
On univariate analysis, female (p=0.004) and palliative patients, p=0.032 were more likely to be CAM users.
Multivariate analysis identified female (p<0.01), as significant for use, whilst head and neck site was significant for
non use (p<0.028). Young, married and highly educated individuals are more likely to use CAM.
Friends and Media are the main sources of information on CAM. There was increase in CAM use after the diagnosis
of cancer mainly for Chinese Medicine and vitamins.
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Conclusion: There is high CAM usage among Cancer patients, comparable to use in the general population, there is
concurrent use of CAM and conventional medicine with reported overlapping toxicity but without informing Oncologist
about use. Women and palliative patients are more likely to use CAM. Doctor patient communication on
herbal-radiotherapy and drug treatment interaction needs to be strengthened. Standardization and regulation of CAM
use is paramount.
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ToxicityBackground
Complementary and alternative medicine (CAM) has been
defined as diagnosis, treatment or prevention that comple-
ments mainstream medicine by contributing to a common
whole, by satisfying a demand not met by orthodoxy or by
diversifying the conceptual framework of medicine [1,2].
Elements of what is referred to as CAM in contemporary
literature were main stream medicine in West Africa prior
to the arrival of “Western Medicine”, it is therefore not a
new phenomenon. In Ghana, about 70% of the population
depend on traditional medicine for their health care. There
is approximately one traditional medicine practitioner for
every 400 people, compared to one allopathic doctor for
every 12, 000 people [3].
Whether an individual uses CAM or not is related to
social and cultural considerations, including paradigm to
disease causation. Chronic disease including cancer is
attributed to the following; poor diets, poor lifestyle prac-
tices, heredity, physical factors, the environment, spiritual
factors and psychological factors [4], health seeking beha-
viour is informed by these factors. In current times there is
often a conflict between legitimized orthodox medicine and
delegitimized traditional herbs and remedies.
The cost of orthodox medicine is often prohibitive to
many individuals, for a large proportion of individuals who
cannot afford these medicines, CAM remains the only
alternative. Additionally the recent proliferation of media
that promote the use of all forms of CAM seem to influ-
ence its use. Unlike conventional therapies that are regu-
lated by law, and require practitioners to be registered and
regulated, CAM practioners are difficult to track, conse-
quences of their practice including untoward effects of the
treatments are not documented.
Cancer is the third leading cause of death in developing
countries [5]. Survival has improved over the years for
many cancers resulting from improvement in conventional
therapies and early presentation [6,7]. Despite this improve-
ment, the effects of the treatment may still be a major
concern to patients sufficiently for them to consider non-
conventional treatment [8]. Indeed, most patients in the
developing world including Ghana are diagnosed at a stage
when most conventional therapies fail; this leads to a
vicious cycle in which patients present late on theunderstanding that nothing can be done anyway, therefore
they may as well resort to other therapies [9].
Acute side effects of chemotherapy and radiotherapy can
occasionally be life threatening, it may affect patient com-
pliance in addition to making them vulnerable to the adop-
tion of alternative forms of treatment which promise cure.
There may be overlapping side effects of treatment, which
worsen the side effects that are caused by conventional
therapies with a potential to have a negative influence on
compliance to treatment thereby diminishing outcomes for
conventional therapy, an example is gastrointestinal toxicity
due to shark cartilage, and used by many for treatment of
cancer even though it has no anti-tumour activity in the
laboratory [10,11]. There could be drug-herb- vitamin
interaction that works to reduce the efficacy of chemother-
apeutic and hormonal treatment. The use of antioxidants
and vitamin C during radiation therapy and chemotherapy
could have a negative impact on outcomes [12]. In spite of
these interactions, majority of patients do not inform their
physician about concurrent use.
Literature from Sub Saharan Africa with respect to the
use of CAM in Cancer patients is sparse, moreover demo-
graphy of patients that are likely to use CAM, and reasons
for use may be different from what pertains in developed
countries because it is related to culture. We do not know
much about concurrent use of CAM, and its potential
consequences.
We therefore undertook to determine the following; (i)
prevalence of CAM use among cancer patients, reasons for
use, whether it is used concurrently with conventional the-
rapies, whether they inform their Oncologist about concur-
rent use, and possible overlapping toxicity,(ii)sources of
information on CAM, (iii) demography (age, sex, marital
status, and level of education of patients who use CAM,(iv)
whether the use of CAM is influenced by the intention to
treat (palliative versus curative),and disease site and (v)
effect of CAM use on treatment compliance.
Methods
A cross-sectional descriptive survey design was used to col-
lect data employing a questionnaire Additional file 1. The
questionnaire on the use of complementary and alternative
medicine designed by Emmanuel Ezeome was adopted and
Yarney et al. BMC Complementary and Alternative Medicine 2013, 13:16 Page 3 of 9
http://www.biomedcentral.com/1472-6882/13/16modified [13]. It was based on the National Center for
Complementary and Alternative Medicine in USA’s classifi-
cation of CAM therapies into five categories. The question-
naire was used to study the use of complementary and
alternative medicine by cancer patients in Nigeria. This
questionnaire which has been validated was chosen because
of the cultural and geographical proximity of the two
countries.
The questionnaire was administered from 11th May 2010
to 25th June 2010 after pretesting among 5 patients
randomly selected from the outpatient department of the
National Center for Radiotherapy and Nuclear Medicine of
Korle Bu Teaching Hospital, Accra, the largest hospital in
Ghana. The respondents had previously received anti-
cancer therapy or were either undergoing radiotherapy or
chemotherapy or both, they may or may not have submit-
ted to Surgery in the past. Based on their responses, appro-
priate changes were made to the questionnaire.
Consent was obtained from each participant prior to ad-
ministration. The questionnaire was administered by one of
the authors who read it out to illiterate patients, the rest
completed it independently. Respondents were either wai-
ting to be seen by a physician, or to be treated.
Respondents were selected by convenient sampling
provided they meet the following criteria; they had to be
18 years of age and above, diagnosed of cancer and
referred to the National Centre for Radiotherapy and
Nuclear Medicine, Korle-Bu Teaching Hospital for
management. Patients, who were blind, deaf and dumb,
mentally retarded or being managed on emergency basis
or with poor performance status were excluded, as were
those who participated in the pilot study.
Clinical characteristics and intention to treat (palliative
versus curative) were gleaned from the patient chart.
Ethical approval was obtained from the Ethical Review
Committee of the School of Allied Health Sciences,
College of Health Sciences, University of Ghana.
Confidentiality of the information that the patients
provided was ensured.
The data collected was analysed using statistical package
for social sciences (SPSS 16.0 software, Chicago, IL).
Descriptive statistics of frequencies and percentages was
used to describe the categorical variables as well as chi-
square contingency table technique. Multivariate analysis
was performed using binary logit regression software, SAS




Ninety eight patients were interviewed, none of the patients
approached to answer the questionnaire declined. Patient
age ranged from 18 to 89, with a mean of 55.5 years and a
standard deviation of 17.1. Male and female respondentswere 48(49%) and 50 (51%) respectively, whilst 55 (56%)
were married and 43 (44%) were either single or divorced.
Fifty respondents representing 51% of patients had received
basic education, whilst 48 of them representing 49% had
undergone either secondary or tertiary education.
Clinical characteristics
Fifteen respondents representing 15.3% had been diagnosed
with cancer of the head and neck region, breast cancer
constituted 21.4%, cancers of the abdomen/pelvic organs
(mainly cervix, rectum, stomach and prostate) comprised
52%, and others; 11.3%. Five respondents (5.1%), received
only chemotherapy, 16(16.3%), received both chemotherapy
and radiotherapy, whilst 77 (78.6%) had radiotherapy only.
0ver 95% of patients were diagnosed of cancer within the
past 24 months of the study. Sixty eight percent of respon-
dents were treated with curative intent, whilst 22% were
treated with palliative intent; the intention to treat was not
available in 10% of cases examined.
Among CAM users, 62.7% noted not abandoning
conventional treatment for CAM. Majority (83.3%) of the
CAM users did not inform their doctors about the CAM
they were using or had used in the past.
Reported side effects include gastric upsets, nausea,
itching, headaches, diarrhoea, and stomach aches. Others
are dizziness, unpleasant smell, water retention, loss of
appetite, and bleeding.
Pattern of CAM use
CAM was used by 73.5% of respondents whilst 26.5% had
not used it at all. Table 1 describes the pattern of CAM use.
Respondents used more than one CAM at a time. Exclud-
ing the column “hope to use” and “used in the past”, the
top five CAM used are Massage (66.3%), Herbal (59.2%),
Mega vitamins (55.1%), Chinese Medicine (53.1%) and
Prayers (42.9%) in decreasing order of use.
How patients got to know about CAM
When asked about how they got to know about the CAM
they were using, they answered as follows; Friends (33.8%),
Mass Media (24.6%), Family members (16.9%), Health
personnel (9.6%), CAM Practitioners (6.2%), Church and
Religious Groups (6.2%), and not sure (4.6%).
Reasons for use or avoidance of CAM
Participants were asked to note their reasons for using
CAM. Among the reasons given were; they wanted to just
try anything (31.2%), based on faith and beliefs (21.9%), and
believing the sickness was spiritual (15.6%). Other reasons
given were, conventional treatment is too mechanical
(12.5%), disappointed in conventional treatment (9.4%), and
conventional treatment is too toxic (9.4%).
Benefits patients expected to derive from the CAM
they used include; to fight the cancer (40.6%), to relieve
Table 1 Pattern of CAM use
Frequency (n)
Types of CAM used by patients Used in the past Used since this cancer Hope to use Both in the past and since this cancer
Biological Based Therapies
High dose/mega vitamins 3 41 2 13
Herbal 8 28 0 30
Mind-Body Systems
Prayers 24 15 2 27
Rituals 1 30 3 1
music therapy 24 5 4 11
Relaxation 13 15 8 9
Support group 1 18 38 5
Alternative Medical Systems
Chinese medicine 0 43 6 9
Indian medicine 0 13 16 1
Acupuncture 0 7 5 0
Homeopathy 0 9 8 0
Manipulative and Body Based Therapies
Chiropractic 0 2 10 0
Osteopathy 2 8 6 1
Massage 3 24 1 41
Reflexology 1 1 11 2
Energy Therapies
Electromagnetic 1 6 11 0
Therapeutic touch 0 3 10 0
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and to relax or sleep (17.4%). Other expected benefits
were to improve the emotional and physical well being
(14.5%) and to assist in wound healing (4.3%).
Non- CAM users were asked to note why they did not
use it. Some had no faith in the effectiveness of CAM,
others never thought of CAM, or were discouraged by
some users of CAM, and yet others believed in the conven-
tional medicine they were receiving and thought CAM was
unnecessary.
Statistical analysis
Tables 2 and 3 depict details of univariate and logistic
regression analysis respectively performed on the data
derived from the questionnaire.
Elements of what is referred to as CAM in contemporary
literature are part of the lifestyle of Ghanaians and West
Africans, and have been practised since antiquity. This is
very different from what is reported in the literature from
Europe and North America. Whether there is concurrent
use of CAM and modern medicine in cancer patients, and
its consequences are not documented in our environment.
In this study we sought to establish whether there is con-
current use of CAM and main stream medicine, prevalenceof CAM use in cancer patients, the kinds of CAM used,
the potential influence of CAM use on compliance to treat-
ment, side effects of CAM, and predictors of CAM use in a
setting where there is a changing paradigm to disease
causation.
Participants were approached and invited to participate
in the completion of the questionnaire instead of using
mailed questionnaire, none of the patients invited to
participate in the study declined (response rate of 100%) .
In mailed questionnaire, non CAM users are likely not to
respond, thus introducing bias, to that extent, our method
is advantageous.
The study was carried out in Korle Bu Teaching Hospital
which provides tertiary services and therefore has a good
mix of rural and urban clientele, drawn from all over the
country but with majority from the south.
While some studies included only a single disease site,
quite a number also involved multiple disease sites like ours
and were not restricted to a particular CAM [13-16].
We found that 73.5% of cancer patients used CAM for
various reasons. This figure is close to the reported preva-
lence of CAM use in the general Ghanaian population of
70%, most patients are therefore CAM users even before
diagnosis and do not stop the practice because they are
Table 2 Contingency table of Patient characteristics and CAM use
CAM USE chi square


































No 5 14 0.665 21.9








Yarney et al. BMC Complementary and Alternative Medicine 2013, 13:16 Page 5 of 9
http://www.biomedcentral.com/1472-6882/13/16
Table 2 Contingency table of Patient characteristics and CAM use (Continued)
Yes
No 19 15.5
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prevention, maintenance and curative purpose [3]. For
instance it is believed that most diseases are caused by
accumulation of mucus in the body, any treatment or con-
coction that removes mucus like laxatives is considered to
have medicinal potential according to CAM practitioners.
It is not uncommon to hear advocates of CAM use adver-
tising this feature even to healthy individuals and encou-
raging its use to promote and maintain health. A study
reported no difference in CAM use between cancer
patients and non cancer patients, this is however not con-
sistent with other studies [14,16].
In a review of 26 surveys from 13 countries carried out
from 1977 to 1998, prevalence of CAM use in cancer
patients was 31.4% with a range of 7% to 64% [17], more
recent studies have reported 70.2% and 83.3% [15,18]. This
may be a reflection of the instrument used, the definition of
CAM and the sample size, nevertheless our reported figure
falls within this range, the only difference is that in our
setting, cancer patients have not resorted to its use only
because of the diagnosis.
The most frequently used CAM types reported is a
reflection of the perception of disease causation. A recent
study on the causes of chronic disease including cancer in
Ghana reported seven causes as follows; poor diets, poorTable 3 Results of logistic regression for the model
Parameter Df Estimate (β)
Intercept 1 0.953
Marital status 1 0.013
Gender 1 −1.012
Age 1 −0.038
Education 0 1 0.544
1 1 −0.761
2 1 −0.345
Tumour site 0 1 −0.297
1 1 −1.476
2 1 0.177
Treatment Intent 0 1 0.199
1 1 −0.712
Marital status (married = 1, single=0) Gender(male=1, female=0); Age was used as a
site (Abd/pel = 0, H/Neck = 1, Thorax = 2, other =3) Treatment Int. (curative = 0, Palifestyle practices, heredity, physical factors, the environ-
ment, spiritual factors and psychological factors. In view of
this, within an individual, there is often a conflict between
the legitimized orthodox medicine and the often frowned
upon local medicine since these ideas are well ingrained
[4]. It is therefore not surprising that patients continue to
use CAM in addition to orthodox medicine.
Massage, herbalism, vitamins, chinese medicine and
prayers are the most subscribed CAM. This is not too
different from studies carried out elsewhere, except that
Massage and Spiritual Practice(Prayers) ranked high,
compared to other cultural settings, but this is similar to
the picture from Nigeria probably because of similarities in
culture [13], the only deviation with respect to other
reports in Africa is the high usage of Chinese Medicine in
Ghana. Chinese medicine, Vitamins and Rituals witnessed
the greatest increase in usage after the diagnosis of cancer.
The least used CAM like osteopathy, reflexology and elec-
tromagnetic touch, may be a reflection of availability rather
than preference for the others [16].
In Ghana, most conventional therapies are out of pocket
payments similar to CAM, insurance cover or affordability
may therefore not necessarily be a predictive factor. There
is however a wide range in the cost of most CAM, ranging
from very expensive to free. Resort to CAM use may be thePr > chisq Odds ratio CI 95%
0.467
0.647 1.295 0.429- 3.912
0.010 0.132 0.028 - 0.617
0.102 0.963 0.920 - 1.008
0.256 0.982 0.189 – 5.104
0.116 0.266 0.46 – 1.532
0.549 0.404 0.059 – 2.768
0.562 0.151 0.026 – 0.869
0.028 0.046 0.005 – 0.421
0.811 0.242 0.026 - 2.263
0.686 0.730 0.102 – 5.208
0.282 0.293 0.025 – 3.85
continuous variable Educ. (Basic = 0, Sec. = 1, Tert. = 2, uneduc. = 3) Tumour
lliative = 1, unspecified =2).
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is high relative to the choice of a particular CAM that is
available to the patient.
Some patients used CAM because they wanted to just try
anything (31.2%); this is a reflection of doubt in the efficacy
of conventional treatment. Majority of patients in the deve-
loping world including Ghana are diagnosed at a stage
when most conventional therapies fail; this is a result of the
absence of screening and educational programmes, as well
as paradigm to disease causation, others also recur after
varying periods of remission and majority become incurable
with conventional therapies. In a study among newly diag-
nosed breast cancer patients, the causes of delayed presen-
tation were: previous medical consultations 26(29.4%),
ignorance 19(28.8%), fear of mastectomy 16(24.2%), herbal
treatment 13(19.7%), prayer/prayer camps 13(19.7%) and
financial incapability 12(18.2%). Fear of mastectomy 20
(57.1%), herbal treatment 13(37.1%), financial incapability
11(31.4%) and prayers/prayer camps 10(28.6%) which were
prominent causes of late presentation, were the main
reasons for absconding [9]. A vicious cycle of late presenta-
tion emanating from paradigm to disease causation leading
to diminished chances of cure and therefore reduced belief
in the efficacy of conventional therapies ensues and
increases subscription to CAM.
Whilst 40.6% of CAM users actually believed that CAM
fights the cancer, majority used it to improve their quality
of life by relieving symptoms caused by the cancer or
conventional therapy(23.2%), relax or sleep(17.4%), for
improvement in the emotional and physical well being
(14.5%) and wound healing(4.3%). This finding is similar to
that found in United States where patients resorted to
CAM to improve their quality of life, boost the immune
system and relieve symptoms [15] but is at variance with
what is reported by patients from Nigeria, United Kingdom
and Turkey where users expected CAM to directly cure
their disease [13,19,20].
Positive results have been reported for some forms of
CAM, for instance, acupuncture has been shown to
relieve chemotherapy induced nausea and vomiting [21],
self-hypnosis, massage or acupuncture induce pain relief
[22], short term improvement in psychological well
being with aromatherapy massage and relief of dyspnoea
with acupuncture, acupressure or relaxation/breathing
techniques [23].
Non users cited lack of belief in the efficacy of CAM,
others were discouraged by previous users reflecting a
negative experience with the use of CAM.
The reported side effects may be a result of the biological
activity of the active ingredients in ingested CAM [24] or
pesticide, fungal and bacterial contamination [25]. There
may be use of incorrect plant species [26], absence of
standardisation (leading to possible substitution, adulte-
ration, incorrect dosing or preparation and inappropriatelabelling or advertising) [27]. Some herbal preparations
have toxic effects (kava causes hepatotoxicity), interact with
prescription drugs (St John Wort), or cause surgical com-
plications (garlic, ginko and ginseng may enhance bleeding
and ginseng causes hypoglycaemia) [27,28].
Pelvic radiation causes inflammation of the bowel
(enteritis and proctitis) in itself, additional gastrointes-
tinal toxicity arising from any of the factors listed is
likely to exacerbate diarrhoea and abdominal cramps.
In a study carried out in Ghana, 52.9% clients of tra-
ditional medicine and 75% orthodox medicine users
claimed that the use of traditional medicine is not safe
as compared to orthodox medicine, but only 17.1% and
5% of traditional medicines users and orthodox medicine
users respectively described traditional medicine usage
as remarkably safe and totally out of harm’s way [29].
The observation that 83.3% of CAM users had not
informed their doctors about CAM use is troubling because
of the issues associated with concurrent use as described
including the negative effect of supplemental anti oxidant
and vitamin administration during radiotherapy and
chemotherapy [12] and the detrimental effect of vitamin E
and Selinium as demonstrated in the SELECT study [30].
In a systematic review comprising 21 studies, 11% to 95%
admitted CAM use, however between 20% and 77% of
users did not disclose their CAM use to their Oncologist.
Reasons cited include; doctors lack of enquiry, patients
anticipation of doctors disapproval, disinterest, or inability
to help, and patients perception that disclosure of CAM
use is irrelevant to their conventional care [31].
Predictors of CAM use in our setting are gender and
intention to treat on univariate analysis (table 2). Women
and patients treated with palliative intent are more likely to
use CAM, with p values of 0.004 and 0.032 respectively.
Age, marital status, level of education and tumour site were
not statistically significant. Our finding in relation to
intention to treat is in agreement with those of Molassiotis
et al., who reported greater use in patients treated with
palliative intent or patients treated for cancers with poorer
prognosis [16]. Kritoffersen et al. also reported higher
prevalence of CAM use among cancer patients with poorer
prognosis, other studies have reported otherwise [32].
Even in an environment of high CAM usage by the ge-
neral population, gender continued to be significant on
multivariate analysis (p=0.01) (table 3). Tumour site was
also seen to be a significant factor affecting the use of CAM
with a p-value of 0.028. It can be said that, those married
are 29.5% more likely to use CAM than singles. Males are
86.8% less likely to use CAM than females. Similarly, a year
increase in age reduces the use of CAM by 3.7%. In other
words younger people have a higher tendency to use CAM.
At the educational level, those with basic, secondary and
tertiary education are 1.8%, 73.4% and 59.6% less likely to
use CAM than the uneducated. As one moves from
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in CAM usage but those with basic education have a higher
usage of CAM. Tumours at the abdominal/pelvic, head and
neck and thoracic areas are 84.9%, 95.4% and 75.8%
respectively less likely than tumours at other parts of the
body to use CAM, particularly head and neck patients are
less likely to use CAM, this is probably due to the difficulty
such patients have with swallowing. These findings are in
agreement with most studies [13-16].
Media and friends constitute the greatest source of
information on CAM. In spite of the fact that radio cove-
rage in Ghana is almost hundred percent, its content with
respect to traditional medicine is hardly regulated, with
vendors making unsubstantiated claims that potentially
influences patient behaviour and preference. The prepara-
tions on the market usually lack labels, and do not report
side effects, dosing is usually verbal. In a recent publication,
buyers were admonished to beware of the potential for
ingested CAM to cause side effects or hinder the efficacy of
conventional therapies [33]. Even though there is an
attempt at regulation by the Traditional Medical Council, it
does not go far enough. The Mampong Center for Research
into Plant Medicine seeks to apply scientific protocols to
the practice of traditional medicine.
Our study is limited by the rather low number of partici-
pants, non-probability sampling method used, and the fact
that it was performed in a single institution. Additionally it
is hospital based, there may be cancer patients who are
CAM users but do not attend hospital at all, their responses
especially in respect of reasons for subscription to CAM
will be interesting. Nevertheless, it provides valuable insight
into the behaviour of cancer patients with respect to CAM
use in an environment where there is high patronage for
CAM in the general population.
Conclusion
There is high usage of CAM in Ghanaian cancer patients,
and majority subscribe to CAM use concurrently with con-
ventional medicine. The main reason for continued use is
to improve quality of life including psychological boost.
These patients are willing to share this information with
their Oncologist, but health personnel fail to ask patients
direct questions on CAM. Such patients tend to be female
and are often treated with palliative intent. Overlapping
toxicity between biological agents and radiotherapy and
chemotherapy were reported, as were intake of agents that
have the potential to reduce the efficacy of conventional
therapies.
It is therefore recommended that Physicians should rou-
tinely ask patients about concurrent use of CAM and con-
ventional therapies in order to provide appropriate advice.
CAM practioners and advertisement in the media on CAM
should be regulated. Public education on risk factors for
cancer should be intensified in order to influence perceivedcauses of cancer and therefore behaviour. Psychological and
Spiritual support should be added to patient care in order
to ensure that evidence based information is provided to
patients. A future study on health professionals’ attitude to
CAM as well as a more detailed study of particular CAM
patients use will be helpful in patient care.Additional file
Additional file 1: Questionnaire on CAM use in cancer patients
undergoing Radiotherapy and Chemotherapy in Ghana.
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